Literature DB >> 28680763

The influence of stromal cells and tumor-microenvironment-derived cytokines and chemokines on CD3+CD8+ tumor infiltrating lymphocyte subpopulations.

Stefan Koeck1,2, Johan Kern1,2, Marit Zwierzina3, Gabriele Gamerith1,2, Edith Lorenz1,2, Sieghart Sopper1,2, Heinz Zwierzina1,2, Arno Amann1,2.   

Abstract

The tumor microenvironment has been identified as a major mediator of immunological processes in solid tumors. In particular, tumor-associated fibroblasts are known to interact with tumor infiltrating immune cells. We describe the influence of fibroblasts and tumor-microenvironment-derived cytokines on the infiltration capacity of CD3+CD8+ cytotoxic T lymphocyte subpopulations using a multicellular 3D co-culture system. 3D tumor microtissues were cultivated using a hanging drop system. Human A549 and Calu-6 cancer cell lines were incubated alone or together with the human fibroblast cell line SV80 for 10 d to form microtissues. On day 10, peripheral blood mononuclear cells (PBMC) were added with or without cytokine stimulation for 24 h. Infiltrating PBMC subpopulations were investigated by flow cytometry. Aggregation of the microtissues and the infiltration of the PBMCs were analyzed by immunohistochemistry, and endogenous cytokine and chemokine expression was analyzed with a multi-cytokine immunoassay. Secretion of chemokines is increased in microtissues consisting of cancer cells and fibroblasts. PBMC infiltrate the whole spheroid in cancer cell monocultures, whereas in co-cultures of cancer cells and fibroblasts, PBMCs are rather localized at the margin. Activated CD69+ and CD49d+ T lymphocytes show an increased microtissue infiltration in the presence of fibroblasts. We demonstrate that the stromal component of cancer microtissues significantly influences immune cell infiltration. The presence of fibroblasts in cancer microtissues induces a shift of T lymphocyte infiltration toward activated T lymphocytes.

Entities:  

Keywords:  3D; biomarker; cancer; co-culture; cytokines; immune cells; infiltration; microenvironment; subpopulation

Year:  2017        PMID: 28680763      PMCID: PMC5486171          DOI: 10.1080/2162402X.2017.1323617

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  29 in total

1.  Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma.

Authors:  Yanyan Lou; Lixia Diao; Edwin Roger Parra Cuentas; Warren L Denning; Limo Chen; You Hong Fan; Lauren A Byers; Jing Wang; Vassiliki A Papadimitrakopoulou; Carmen Behrens; Jaime Canales Rodriguez; Patrick Hwu; Ignacio I Wistuba; John V Heymach; Don L Gibbons
Journal:  Clin Cancer Res       Date:  2016-02-05       Impact factor: 12.531

Review 2.  Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression.

Authors:  Peter J Chockley; Venkateshwar G Keshamouni
Journal:  J Immunol       Date:  2016-08-01       Impact factor: 5.422

3.  Effector memory T cells, early metastasis, and survival in colorectal cancer.

Authors:  Franck Pagès; Anne Berger; Matthieu Camus; Fatima Sanchez-Cabo; Anne Costes; Robert Molidor; Bernhard Mlecnik; Amos Kirilovsky; Malin Nilsson; Diane Damotte; Tchao Meatchi; Patrick Bruneval; Paul-Henri Cugnenc; Zlatko Trajanoski; Wolf-Herman Fridman; Jérôme Galon
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

4.  Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.

Authors:  Marie-Caroline Dieu-Nosjean; Martine Antoine; Claire Danel; Didier Heudes; Marie Wislez; Virginie Poulot; Nathalie Rabbe; Ludivine Laurans; Eric Tartour; Luc de Chaisemartin; Serge Lebecque; Wolf-Herman Fridman; Jacques Cadranel
Journal:  J Clin Oncol       Date:  2008-09-20       Impact factor: 44.544

Review 5.  Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue.

Authors:  George S Karagiannis; Theofilos Poutahidis; Susan E Erdman; Richard Kirsch; Robert H Riddell; Eleftherios P Diamandis
Journal:  Mol Cancer Res       Date:  2012-09-28       Impact factor: 5.852

Review 6.  CD8+ T-cell memory in tumor immunology and immunotherapy.

Authors:  Christopher A Klebanoff; Luca Gattinoni; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2006-06       Impact factor: 12.988

7.  Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness.

Authors:  Elisa Giannoni; Francesca Bianchini; Lorenzo Masieri; Sergio Serni; Eugenio Torre; Lido Calorini; Paola Chiarugi
Journal:  Cancer Res       Date:  2010-08-10       Impact factor: 12.701

Review 8.  The fibroblast: sentinel cell and local immune modulator in tumor tissue.

Authors:  Tobias Silzle; Gwendalyn J Randolph; Marina Kreutz; Leoni A Kunz-Schughart
Journal:  Int J Cancer       Date:  2004-01-10       Impact factor: 7.396

9.  Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.

Authors:  Patsy S H Soon; Edward Kim; Cindy K Pon; Anthony J Gill; Katrina Moore; Andrew J Spillane; Diana E Benn; Robert C Baxter
Journal:  Endocr Relat Cancer       Date:  2013-01-07       Impact factor: 5.678

10.  Mesenchymal stromal cells induce epithelial-to-mesenchymal transition in human colorectal cancer cells through the expression of surface-bound TGF-β.

Authors:  Valentina Mele; Manuele G Muraro; Diego Calabrese; Dennis Pfaff; Nunzia Amatruda; Francesca Amicarella; Brynn Kvinlaug; Chiara Bocelli-Tyndall; Ivan Martin; Therese J Resink; Michael Heberer; Daniel Oertli; Luigi Terracciano; Giulio C Spagnoli; Giandomenica Iezzi
Journal:  Int J Cancer       Date:  2014-01-30       Impact factor: 7.396

View more
  7 in total

1.  Metastatic Tumor-in-a-Dish, a Novel Multicellular Organoid to Study Lung Colonization and Predict Therapeutic Response.

Authors:  Prabhu Ramamoorthy; Sufi Mary Thomas; Gaurav Kaushik; Dharmalingam Subramaniam; Katherine M Chastain; Animesh Dhar; Ossama Tawfik; Anup Kasi; Weijing Sun; Satish Ramalingam; Sumedha Gunewardena; Shahid Umar; Joshua M Mammen; Subhash B Padhye; Scott J Weir; Roy A Jensen; G Sitta Sittampalam; Shrikant Anant
Journal:  Cancer Res       Date:  2019-01-23       Impact factor: 12.701

Review 2.  Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy.

Authors:  Elena García-Martínez; Melody Smith; Aitziber Buqué; Fernando Aranda; Francisco Ayala de la Peña; Alejandra Ivars; Manuel Sanchez Cánovas; Ma Angeles Vicente Conesa; Jitka Fucikova; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2018-02-15       Impact factor: 8.110

Review 3.  Biomarkers and 3D models predicting response to immune checkpoint blockade in head and neck cancer (Review).

Authors:  Annette Affolter; Johann Kern; Karen Bieback; Claudia Scherl; Nicole Rotter; Anne Lammert
Journal:  Int J Oncol       Date:  2022-06-01       Impact factor: 5.884

Review 4.  Engineered in vitro tumor models for cell-based immunotherapy.

Authors:  Yuta Ando; Chelsea Mariano; Keyue Shen
Journal:  Acta Biomater       Date:  2021-04-20       Impact factor: 10.633

5.  Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment.

Authors:  Tristan Courau; Julie Bonnereau; Justine Chicoteau; Hugo Bottois; Romain Remark; Laura Assante Miranda; Antoine Toubert; Mathieu Blery; Thomas Aparicio; Matthieu Allez; Lionel Le Bourhis
Journal:  J Immunother Cancer       Date:  2019-03-14       Impact factor: 13.751

Review 6.  Tumor Microenvironment and Hydrogel-Based 3D Cancer Models for In Vitro Testing Immunotherapies.

Authors:  Chiara Vitale; Monica Marzagalli; Silvia Scaglione; Alessandra Dondero; Cristina Bottino; Roberta Castriconi
Journal:  Cancers (Basel)       Date:  2022-02-17       Impact factor: 6.639

7.  Expression of Programmed Death-Ligand 1 and Programmed Death-1 in Patients with Extramammary Paget's Disease.

Authors:  Hiroyuki Goto; Kazunari Sugita; Osamu Yamamoto
Journal:  Indian J Dermatol       Date:  2021 Mar-Apr       Impact factor: 1.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.